Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT02073838Phase 2Completed
Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
Acute Myeloid Leukemia
PrincipalinvestigatorStart date: 2015-05-01
NCT00559091Phase 2Completed
A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia
Acute Myelocytic Leukemia
Principalinvestigator

Research Network

Collaboration Network

25 collaborators·71 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell+1 more
Similarity Score30%

Arnon Nagler, MD

Chaim Sheba Medical Center

Moderately Similar
12 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Lymphocytic, Chronic, B-Cell+1 more

Worked with same sponsors:

University of Milano Bicocca
Similarity Score30%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, AcuteLymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Novartis Pharmaceuticals
Similarity Score23%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoma, Large B-Cell, Diffuse
Similarity Score23%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute
Similarity Score23%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score23%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Worked with same sponsors:

NovartisNovartis Pharmaceuticals
Similarity Score15%

Jorge E Cortes, MD

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Worked with same sponsors:

NovartisNovartis Pharmaceuticals
Similarity Score15%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04621851PrincipalInvestigator

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

Chronic Myeloid Leukemia
Completed
NCT02073838Phase 2PrincipalInvestigator

Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML

Acute Myeloid Leukemia
Completed
NCT00558961Phase 1/2PrincipalInvestigator

Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients

Chronic Lymphocytic Leukemia
Terminated
NCT00559091Phase 2PrincipalInvestigator

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

Acute Myelocytic Leukemia
Completed
NCT01238692Phase 2PrincipalInvestigator

A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)

Diffuse Large B Cell Lymphoma
Completed

All 5 trials loaded